Grants
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) (PAR-24-096)
Sponsor
National Institute of Neurological Disorders and Stroke
Award
Budgets up to $700,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested.
Due Date
Multiple due dates; see announcement.